What is EliseAI?
Headquartered in New York City, EliseAI operates as a sophisticated machine learning technology company that specializes in automating complex, high-volume communication workflows. The company's unified platform serves as a digital backbone for property management and healthcare organizations, facilitating seamless interactions such as lead response, patient intake, maintenance scheduling, and lease renewals. By integrating CRM capabilities with advanced natural language processing, EliseAI enables organizations to reduce operational overhead while simultaneously improving the end-user experience. The platform's ability to support voice interactions in seven languages and written communication in 51 languages positions it as a uniquely scalable solution for global enterprise clients. With a focus on sectors ranging from women's health to commercial real estate, the company has established itself as the largest AI-native entity within its niche, processing millions of rental units and patient appointments annually.
How much funding has EliseAI raised?
EliseAI has raised a total of $495M across 3 funding rounds:
Series C
$35M
Series E
$250M
Stock/Share Issuance
$210M
Series C (2023): $35M with participation from Golden Seeds, Navitas Capital, DivcoWest, and JLL Spark
Series E (2025): $250M led by Navitas Capital, Sapphire Ventures, Bessemer Venture Partners, and Andreessen Horowitz
Stock/Share Issuance (2025): $210M, investors not publicly disclosed
Key Investors in EliseAI
Navitas Capital
A venture capital firm specializing in transformative technology and innovation within the built environment, focusing on AI, digitization, and sustainability.
Sapphire Ventures
A Palo Alto-based venture capital firm dedicated to investing in and providing strategic services to high-growth technology companies.
Bessemer Venture Partners
A long-standing venture capital firm with a global footprint, known for supporting early-stage and growth-stage startups across diverse technology sectors.
What's next for EliseAI?
With the successful closure of this major strategic investment, EliseAI is well-positioned to accelerate its product roadmap and deepen its penetration into the healthcare and real estate markets. The company is expected to prioritize the expansion of its language processing capabilities and the integration of more complex, industry-specific workflows into its existing CRM modules. Furthermore, the influx of capital will likely support the scaling of its engineering and sales teams to meet the growing demand for AI-driven operational efficiency. As the firm continues to refine its conversational AI agents, it remains focused on maintaining its competitive edge through continuous innovation and strategic partnerships, ensuring that its platform remains the standard for automated enterprise communication.
See full EliseAI company page
